Cargando…
The Effect of FDA Drug Safety Communications on Patterns of Tiotropium Dispensing: A U.S. Health Plan Claims Database Study
BACKGROUND: The FDA issued 2 main drug safety communications (DSCs) on the cardiovascular safety of tiotropium in March 2008 (warning of a potential increased stroke risk) and January 2010 (informing of an absence of a significant increased stroke risk or cardiovascular events based on findings from...
Autores principales: | Major, Jacqueline M., Zhou, Esther H., Ding, Yulan, Ly, Thomas, Li, Jie, Pinheiro, Simone P., Seymour, Sally |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398184/ https://www.ncbi.nlm.nih.gov/pubmed/29952703 http://dx.doi.org/10.18553/jmcp.2018.24.7.700 |
Ejemplares similares
-
Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database
por: Quint, Jennifer K., et al.
Publicado: (2021) -
The US Food and Drug Administration’s drug safety recommendations and long-acting beta2-agonist dispensing pattern changes in adult asthma patients: 2003–2012
por: Zhou, Esther H, et al.
Publicado: (2017) -
Trends in clinical trial investigator workforce and turnover: An analysis of the U.S. FDA 1572 BMIS database
por: Fordyce, Christopher B., et al.
Publicado: (2019) -
The Effects of the FDA Warning on the Use of Droperidol by U.S. Emergency Physicians
por: Richards, John R., et al.
Publicado: (2003) -
Use of Sildenafil in Pulmonary Arterial Hypertension: Findings from a U.S. Healthcare Claims Database
por: Berger, Ariel, et al.
Publicado: (2014)